Discharge hospice referral and lower 30-day all-cause readmission in medicare beneficiaries hospitalized for heart failure

Circulation: Heart Failure

Volumn 8, Issue 4, 2015, Pages 733-740

  Kheirbek, Raya E ^a,b   Fletcher, Ross D ^a,c   Bakitas, Marie A ^d,e   Fonarow, Gregg C ^h   Parvataneni, Sridivya ⁱ   Bearden, Donna ^e   Bailey, Frank A ^j   Morgan, Charity J ^f   Singh, Steven ^a,c   Blackman, Marc R ^a,b,c   Zile, Michael R ^k,l   Patel, Kanan ^m   Ahmed, Momanna B ^e   Tucker, Rodney O ^e   Brown, Cynthia J ^e,n   Love, Thomas E ^o   Aronow, Wilbert S ^p   Roseman, Jeffrey M ^g   Rich, Michael W ^q   Allman, Richard M ^r   Ahmed, Ali ^a,c,e   more..

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^c GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Acute Care Section   (United States)

^e Departments of Medicine   (United States)

^f Departments of A Biostatistics   (United States)

^g UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ East Tennessee State University   (United States)

^j UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^k MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^l RALPH H JOHNSON VA MEDICAL CENTER   (United States)

^m UNIVERSITY OF CALIFORNIA   (United States)

ⁿ BIRMINGHAM VA MEDICAL CENTER   (United States)

^o CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^p NEW YORK MEDICAL COLLEGE   (United States)

^q WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^r DEPARTMENT OF VETERANS AFFAIRS   (United States)

more..

Author keywords

Heart failure; Hospice; Medicare; readmission

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOOP DIURETIC AGENT;

ACUTE HEART FAILURE; ADULT; AGED; ARTICLE; CARDIAC PATIENT; CARDIOVASCULAR MORTALITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HOSPICE; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICARE; MULTICENTER STUDY; PATIENT REFERRAL; PRIORITY JOURNAL; PROPENSITY SCORE; VERY ELDERLY; CHI SQUARE DISTRIBUTION; EPIDEMIOLOGY; HEART FAILURE; HOSPITAL ADMISSION; INSURANCE; KAPLAN MEIER METHOD; LENGTH OF STAY; MORTALITY; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODEL; REGISTER; RISK ASSESSMENT; RISK FACTOR; TIME; UNITED STATES;

AGED; AGED, 80 AND OVER; ALABAMA; CHI-SQUARE DISTRIBUTION; FEMALE; HEART FAILURE; HOSPICES; HUMANS; INSURANCE BENEFITS; KAPLAN-MEIER ESTIMATE; LENGTH OF STAY; MALE; MEDICARE; MULTIVARIATE ANALYSIS; PATIENT ADMISSION; PATIENT DISCHARGE; PATIENT READMISSION; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODELS; REFERRAL AND CONSULTATION; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; UNITED STATES;

EID: 84942911345     PISSN: 19413289     EISSN: 19413297     Source Type: Journal    
DOI: 10.1161/CIRCHEARTFAILURE.115.002153     Document Type: Article

References (40)

1. Jencks SF, Williams MV, Coleman EA. Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med. 2009;360:1418-1428. doi: 10.1056/NEJMsa0803563.
2. Rau J. Hospitals Face Pressure to avert readmissions. The New York Times. New York, NY. Published online November 26, 2012. http://www. Nytimes.Com/2012/11/27/health/hospitals-face-pressure-from-medicareto-avert-readmissions.Html?-r=0. Accessed December 2, 2012.
3. Feltner C, Jones CD, Cen CW, Zheng ZJ, Sueta CA, Coker-Schwimmer EJ, Arvanitis M, Lohr KN, Middleton JC, Jonas DE. Transitional care interventions to prevent readmissions for persons with heart failure: a systematic review and meta-analysis. Ann Intern Med. 2014;160:774-784. doi: 10.7326/M14-0083.
4. Bourge RC, Fleg JL, Fonarow GC, Cleland JG, McMurray JJ, van Veldhuisen DJ, Gheorghiade M, Patel K, Aban IB, Allman RM, White-Williams C, White M, Filippatos GS, Anker SD, Ahmed A. Digoxin reduces 30-day all-cause hospital admission in older patients with chronic systolic heart failure. Am J Med. 2013;126:701-708. doi: 10.1016/j. amjmed.2013.02.001.
5. Hashim T, Elbaz S, Patel K, Morgan CJ, Fonarow GC, Fleg JL, McGwin G, Cutter GR, Allman RM, Prabhu SD, Zile MR, Bourge RC, Ahmed A. Digoxin and 30-day all-cause hospital admission in older patients with chronic diastolic heart failure. Am J Med. 2014;127:132-139. doi: 10.1016/j.amjmed.2013.08.006.
6. Ahmed A, Bourge RC, Fonarow GC, Patel K, Morgan CJ, Fleg JL, Aban IB, Love TE, Yancy CW, Deedwania P, van Veldhuisen DJ, Filippatos GS, Anker SD, Allman RM. Digoxin use and lower 30-day all-cause readmission for Medicare beneficiaries hospitalized for heart failure. Am J Med. 2014;127:61-70. doi: 10.1016/j.amjmed.2013.08.027.
7. Sanam K, Bhatia V, Parvataneni S, Morgan CJ, Lloyd S, Hage F, D. PS, Fonarow GC, Aronow WS, Mujib M, Deedwania P, Butler J, White M, Anker SD, Allman RM, Ahmed A. Discharge initiation of ACE inhibitors or ARBS is associated with significantly lower 30-day all-cause readmission in hospitalized older patients with heart failure and reduced ejection fraction. J Am Coll Cardiol. 2014;63:12s.
8. Bhatia V, Bajaj NS, Sanam K, Hashim T, Morgan CJ, Prabhu SD, Fonarow GC, Deedwania P, Butler J, Carson P, Love TE, Kheirbek R, Aronow WS, Anker SD, Waagstein F, Fletcher R, Allman RM, Ahmed A. Beta-blocker use and 30-day all-cause readmission in Medicare beneficiaries with systolic heart failure [published online ahead of print December 29, 2014]. Am J Med. doi: 10.1016/j.amjmed.2014.11.036.
9. Inampudi C, Parvataneni S, Morgan CJ, Deedwania P, Fonarow GC, Prabhu SD, Butler J, Zile MR, Aronow WS, Sanders PW, Allman RM, Ahmed A. Lack of association between spironolactone use and 30-day all-cause readmission in hospitalized medicare beneficiaries with systolic heart failure eligible for spironolactone therapy. J Card Failure. 2014;20:58S.
10. Fonarow GC, Stough WG, Abraham WT, Albert NM, Gheorghiade M, Greenberg BH, OConnor CM, Sun JL, Yancy CW, Young JB; OPTIMIZE-HF Investigators and Hospitals. Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry. J Am Coll Cardiol. 2007;50:768-777. doi: 10.1016/j.jacc.2007.04.064.
11. Bakitas M, Macmartin M, Trzepkowski K, Robert A, Jackson L, Brown JR, Dionne-Odom JN, Kono A. Palliative care consultations for heart failure patients: how many, when, and why? J Card Fail. 2013;19:193-201. doi: 10.1016/j.cardfail.2013.01.011.
12. Feller MA, Mujib M, Zhang Y, Ekundayo OJ, Aban IB, Fonarow GC, Allman RM, Ahmed A. Baseline characteristics, quality of care, and outcomes of younger and older Medicare beneficiaries hospitalized with heart failure: findings from the Alabama Heart Failure Project. Int J Cardiol. 2012;162:39-44. doi: 10.1016/j.ijcard.2011.05.003.
13. Rosenbaum PR, Rubin DB. The central role of propensity score in observational studies for causal effects. Biometrika. 1983;70:41-55.
14. Rubin DB. Using propensity score to help design observational studies: application to the tobacco litigation. Health Serv Outcomes Res Methodol. 2001;2:169-188.
15. Ahmed A, Husain A, Love TE, Gambassi G, DellItalia LJ, Francis GS, Gheorghiade M, Allman RM, Meleth S, Bourge RC. Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods. Eur Heart J. 2006;27:1431-1439. doi: 10.1093/eurheartj/ehi890.
16. Ahmed A, Rich MW, Love TE, Lloyd-Jones DM, Aban IB, Colucci WS, Adams KF, Gheorghiade M. Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial. Eur Heart J. 2006;27:178-186. doi: 10.1093/eurheartj/ehi687.
17. Ahmed A, Fonarow GC, Zhang Y, Sanders PW, Allman RM, Arnett DK, Feller MA, Love TE, Aban IB, Levesque R, Ekundayo OJ, DellItalia LJ, Bakris GL, Rich MW. Renin-angiotensin inhibition in systolic heart failure and chronic kidney disease. Am J Med. 2012;125:399-410. doi: 10.1016/j.amjmed.2011.10.013.
18. Ahmed A, Rich MW, Zile M, Sanders PW, Patel K, Zhang Y, Aban IB, Love TE, Fonarow GC, Aronow WS, Allman RM. Renin-angiotensin inhibition in diastolic heart failure and chronic kidney disease. Am J Med. 2013;126:150-161. doi: 10.1016/j.amjmed.2012.06.031.
19. Mujib M, Patel K, Fonarow GC, Kitzman DW, Zhang Y, Aban IB, Ekundayo OJ, Love TE, Kilgore ML, Allman RM, Gheorghiade M, Ahmed A. Angiotensin-converting enzyme inhibitors and outcomes in heart failure and preserved ejection fraction. Am J Med. 2013;126:401-410. doi: 10.1016/j.amjmed.2013.01.004.
20. Rosenbaum PR. Sensitivity to hidden bias. In: Rosenbaum PR, ed. Observational Studies. New York, NY: Springer-Verlag; 2002:105-170.
21. Zile MR, Gaasch WH, Anand IS, Haass M, Little WC, Miller AB, Lopez-Sendon J, Teerlink JR, White M, McMurray JJ, Komajda M, McKelvie R, Ptaszynska A, Hetzel SJ, Massie BM, Carson PE; I-Preserve Investigators. Mode of death in patients with heart failure and a preserved ejection fraction: results from the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-Preserve) trial. Circulation. 2010;121:1393-1405. doi: 10.1161/CIRCULATIONAHA.109.909614.
22. Kheirbek RE, Alemi F, Citron BA, Afaq MA, Wu H, Fletcher RD. Trajectory of illness for patients with congestive heart failure. J Palliat Med. 2013;16:478-484. doi: 10.1089/jpm.2012.0510.
23. Barnes S, Gott M, Payne S, Parker C, Seamark D, Gariballa S, Small N. Predicting mortality among a general practice-based sample of older people with heart failure. Chronic Illn. 2008;4:5-12. doi: 10.1177/1742395307083783.
24. Levenson JW, McCarthy EP, Lynn J, Davis RB, Phillips RS. The last six months of life for patients with congestive heart failure. J Am Geriatr Soc. 2000;48(suppl 5):S101-S109.
25. Enguidanos S, Vesper E, Lorenz K. 30-day readmissions among seriously ill older adults. J Palliat Med. 2012;15:1356-1361. doi: 10.1089/jpm.2012.0259.
26. National Hospice and Palliative Care Organization. NHPCOs Facts and Figures: Hospice Care in America 2014 Edition. http://www.Nhpco. Org/sites/default/files/public/statistics-research/2014-facts-figures.Pdf. Accessed June 5, 2015.
27. Wachterman MW, Marcantonio ER, Davis RB, McCarthy EP. Association of hospice agency profit status with patient diagnosis, location of care, and length of stay. JAMA. 2011;305:472-479. doi: 10.1001/jama.2011.70.
28. Adler ED, Goldfinger JZ, Kalman J, Park ME, Meier DE. Palliative care in the treatment of advanced heart failure. Circulation. 2009;120:2597-2606. doi: 10.1161/CIRCULATIONAHA.109.869123.
29. Goodlin SJ. Palliative care in congestive heart failure. J Am Coll Cardiol. 2009;54:386-396. doi: 10.1016/j.jacc.2009.02.078.
30. Lindenfeld J, Albert NM, Boehmer JP, Collins SP, Ezekowitz JA, Givertz MM, Katz SD, Klapholz M, Moser DK, Rogers JG, Starling RC, Stevenson WG, Tang WH, Teerlink JR, Walsh MN; Heart Failure Society of America. HFSA 2010 Comprehensive Heart Failure Practice Guideline. J Card Fail. 2010;16:e1-194. doi: 10.1016/j.cardfail.2010.04.004.
31. Solomon DH, Rassen JA, Glynn RJ, Lee J, Levin R, Schneeweiss S. The comparative safety of analgesics in older adults with arthritis. Arch Intern Med. 2010;170:1968-1976. doi: 10.1001/archinternmed.2010.391.
32. Peacock WF, Hollander JE, Diercks DB, Lopatin M, Fonarow G, Emerman CL. Morphine and outcomes in acute decompensated heart failure: an ADHERE analysis. Emerg Med J. 2008;25:205-209. doi: 10.1136/emj.2007.050419.
33. Cuffe MS, Califf RM, Adams KF Jr, Benza R, Bourge R, Colucci WS, Massie BM, OConnor CM, Pina I, Quigg R, Silver MA, Gheorghiade M; Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) Investigators. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. JAMA. 2002;287:1541-1547.
34. Packer M, Carver JR, Rodeheffer RJ, Ivanhoe RJ, DiBianco R, Zeldis SM, Hendrix GH, Bommer WJ, Elkayam U, Kukin ML. Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. N Engl J Med. 1991;325:1468-1475. doi: 10.1056/NEJM199111213252103.
35. Teno JM, Plotzke M, Gozalo P, Mor V. A national study of live discharges from hospice. J Palliat Med. 2014;17:1121-1127. doi: 10.1089/jpm.2013.0595.
36. Konstam MA. Heart failure in the lifetime of Musca domestica (the common housefly). JACC Heart Fail. 2013;1:178-180. doi: 10.1016/j. jchf.2013.02.003.
37. Greener DT, Quill T, Amir O, Szydlowski J, Gramling RE. Palliative care referral among patients hospitalized with advanced heart failure. J Palliat Med. 2014;17:1115-1120. doi: 10.1089/jpm.2013.0658.
38. Unroe KT, Greiner MA, Hernandez AF, Whellan DJ, Kaul P, Schulman KA, Peterson ED, Curtis LH. Resource use in the last 6 months of life among medicare beneficiaries with heart failure, 2000-2007. Arch Intern Med. 2011;171:196-203. doi: 10.1001/archinternmed.2010.371.
39. Holden TR, Smith MA, Bartels CM, Campbell TC, Yu M, Kind AJ. Hospice enrollment, local hospice utilization patterns, and rehospitalization in Medicare patients [published online ahead of print April 16, 2015]. J Palliat Med. doi:10.1089/jpm.2014.0395.
40. Butler J, Binney Z, Kalogeropoulos A, Owen M, Clevenger C, Gunter D, Georgiopoulou V, Quest T. Advance directives among hospitalized patients with heart failure. JACC Heart Fail. 2015;3:112-121. doi: 10.1016/j.jchf.2014.07.016.